Pfizer and Innovent Biologics Announce Potential 105 Billion Drug Deal VRT Q1 2026 Earnings EPS Surges Past Estimates by 16 Revenue Details Not Disclosed BIS Highlights PostGFC Transformation of Global Financial System MBAI Q3 2023 Earnings EPS Misses Estimates as PreRevenue Company Continues Development DOCS Q1 2026 Earnings EPS Misses Estimates Stock Surprises with Gains CCU Q1 2026 Earnings Strong EPS Beat Amidst Challenging Environment SPOK Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed APLE Q1 2026 Earnings FFO Per Share Misses Estimates as Operating Costs Rise BHRB Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher KDK Q1 2026 Earnings Profitability Breakthrough as EPS Smashes Estimates Stock Declines OABI Q1 2026 Earnings EPS Beats Expectations by 4118 Despite No Revenue Reported